X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21817) 21817
Magazine Article (254) 254
Book Chapter (137) 137
Newspaper Article (45) 45
Publication (38) 38
Newsletter (35) 35
Dissertation (32) 32
Book / eBook (31) 31
Conference Proceeding (7) 7
Patent (4) 4
Web Resource (4) 4
Government Document (2) 2
Journal / eJournal (1) 1
Paper (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15201) 15201
administration, oral (8096) 8096
female (7726) 7726
male (7390) 7390
warfarin (5738) 5738
anticoagulants (5302) 5302
anticoagulants - administration & dosage (5243) 5243
aged (5130) 5130
middle aged (4955) 4955
anticoagulants - therapeutic use (4860) 4860
atrial fibrillation (3996) 3996
adult (3773) 3773
anticoagulants - adverse effects (3620) 3620
risk factors (3612) 3612
hematology (3408) 3408
stroke (3054) 3054
peripheral vascular disease (3004) 3004
cardiac & cardiovascular systems (2975) 2975
oral anticoagulants (2929) 2929
treatment outcome (2788) 2788
dabigatran (2679) 2679
rivaroxaban (2625) 2625
pharmacology & pharmacy (2372) 2372
aged, 80 and over (2366) 2366
thromboembolism (2354) 2354
atrial fibrillation - drug therapy (2307) 2307
risk (2282) 2282
venous thromboembolism (2276) 2276
prevention (2268) 2268
management (2248) 2248
therapy (2118) 2118
hemorrhage - chemically induced (2023) 2023
medicine, general & internal (1989) 1989
oral anticoagulation (1914) 1914
atrial-fibrillation (1902) 1902
stroke - prevention & control (1832) 1832
thrombosis (1799) 1799
animals (1741) 1741
international normalized ratio (1704) 1704
atrial fibrillation - complications (1696) 1696
surgery (1671) 1671
anticoagulation (1647) 1647
warfarin - therapeutic use (1571) 1571
apixaban (1553) 1553
care and treatment (1510) 1510
analysis (1504) 1504
warfarin - administration & dosage (1503) 1503
time factors (1492) 1492
retrospective studies (1479) 1479
medicine & public health (1432) 1432
dentistry, oral surgery & medicine (1384) 1384
safety (1356) 1356
direct oral anticoagulants (1354) 1354
bleeding (1337) 1337
abridged index medicus (1297) 1297
patients (1285) 1285
dentistry (1273) 1273
warfarin - adverse effects (1248) 1248
stroke prevention (1239) 1239
risk assessment (1209) 1209
thromboembolism - prevention & control (1196) 1196
antithrombotic therapy (1175) 1175
oral anticoagulant-therapy (1173) 1173
prospective studies (1149) 1149
drug therapy (1138) 1138
aspirin (1126) 1126
adolescent (1107) 1107
vitamin k - antagonists & inhibitors (1098) 1098
health aspects (1094) 1094
mortality (1081) 1081
dose-response relationship, drug (1064) 1064
stroke - etiology (1057) 1057
hemorrhage (1052) 1052
follow-up studies (1044) 1044
deep-vein thrombosis (1038) 1038
blood coagulation - drug effects (1037) 1037
cardiac arrhythmia (1032) 1032
research (1001) 1001
pharmacokinetics (989) 989
molecular-weight heparin (969) 969
anticoagulants - pharmacology (928) 928
cardiology (923) 923
risk-factors (893) 893
efficacy (889) 889
internal medicine (889) 889
young adult (879) 879
metaanalysis (853) 853
clinical trials (845) 845
prothrombin time (839) 839
dosage and administration (835) 835
drug interactions (829) 829
drug administration schedule (800) 800
thrombin (797) 797
venous thrombosis (740) 740
heparin (726) 726
incidence (723) 723
medical research (715) 715
oral anticoagulant (699) 699
randomized controlled trials as topic (694) 694
recurrence (694) 694
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Dentistry (Harry R Abbott) - Stacks (8) 8
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (3) 3
Gerstein Science - Stacks (3) 3
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20154) 20154
German (695) 695
French (467) 467
Spanish (376) 376
Russian (163) 163
Italian (156) 156
Japanese (152) 152
Portuguese (97) 97
Polish (71) 71
Hungarian (46) 46
Turkish (25) 25
Dutch (24) 24
Danish (21) 21
Chinese (20) 20
Czech (20) 20
Swedish (16) 16
Norwegian (15) 15
Korean (10) 10
Hebrew (9) 9
Bulgarian (6) 6
Finnish (6) 6
Serbian (6) 6
Slovenian (5) 5
Croatian (4) 4
Romanian (4) 4
Icelandic (2) 2
Lithuanian (2) 2
Arabic (1) 1
Bosnian (1) 1
Estonian (1) 1
Georgian (1) 1
Persian (1) 1
Slovak (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2014, Volume 64, Issue 11, pp. 1128 - 1139
Journal Article
Clinics in laboratory medicine, 09/2014, Volume 34, Issue 3, pp. xiii - xv
...Jerrold H. Levy, MD, FAHA, FCCM, Editor Anticoagulants have increasingly become a therapeutic mainstay in the management of patients for multiple prophylactic... 
Anticoagulants - administration & dosage | Blood Coagulation - drug effects | Administration, Oral | Hemorrhage - therapy | Humans | Anticoagulants - therapeutic use | Hemorrhage - prevention & control | Hemorrhage - chemically induced | Anticoagulants - adverse effects | Drug Monitoring
Journal Article
The American journal of medicine, ISSN 0002-9343, 2014, Volume 127, Issue 11, pp. 1075 - 1082.e1
Journal Article
Thrombosis and haemostasis, ISSN 0340-6245, 2016, Volume 115, Issue 4, pp. 685 - 711
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2017, Volume 151, Issue 1, pp. 127 - 138
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e44S - e88S
Background: The objective of this article is to summarize the published literature concerning the pharmacokinetics and pharmacodynamics of oral anticoagulant drugs that are currently available for clinical use... 
GAMMA-CARBOXYGLUTAMIC ACID | INTRAVENOUS PHYTONADIONE VITAMIN-K-1 | FACTOR-XA INHIBITOR | VENOUS LIMB GANGRENE | EUROPEAN CONCERTED ACTION | LOW-INTENSITY WARFARIN | RESPIRATORY SYSTEM | VITAMIN-K ANTAGONISTS | TOTAL HIP-REPLACEMENT | INTERNATIONAL NORMALIZED RATIO | NONVALVULAR ATRIAL-FIBRILLATION | CRITICAL CARE MEDICINE | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | United States | Humans | Pyridines - pharmacokinetics | Antithrombins - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Antithrombins - pharmacokinetics | Dose-Response Relationship, Drug | Rivaroxaban | Pyridines - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Benzimidazoles - administration & dosage | Thrombosis - blood | Thrombosis - prevention & control | Benzimidazoles - adverse effects | Morpholines - adverse effects | Pyridines - administration & dosage | Administration, Oral | Morpholines - administration & dosage | Benzimidazoles - pharmacokinetics | Anticoagulants - adverse effects | Evidence-Based Medicine | Factor Xa - metabolism | Thiophenes - pharmacokinetics | Vitamin K - blood | Antithrombins - adverse effects | Anticoagulants - pharmacokinetics | Thrombosis - drug therapy | Morpholines - pharmacokinetics | Practice Guidelines as Topic | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e152S - e184S
Background: High-quality anticoagulation management is required to keep these narrow therapeutic index medications as effective and safe as possible. This... 
COMPUTERIZED DECISION-SUPPORT | INTENSITY WARFARIN THERAPY | DEFINITE ANTIPHOSPHOLIPID SYNDROME | RESPIRATORY SYSTEM | PROTHROMBIN COMPLEX CONCENTRATE | MOLECULAR-WEIGHT HEPARIN | DEEP-VEIN THROMBOSIS | INTERNATIONAL NORMALIZED RATIO | NONVALVULAR ATRIAL-FIBRILLATION | ACUTE VENOUS THROMBOEMBOLISM | ORAL VITAMIN-K | CRITICAL CARE MEDICINE | United States | Humans | Decision Support Systems, Clinical | Heparin - therapeutic use | Hemorrhage - prevention & control | Long-Term Care | Heparin - adverse effects | Heparin - pharmacokinetics | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Drug Interactions | Societies, Medical | Fibrinolytic Agents - pharmacokinetics | Drug-Related Side Effects and Adverse Reactions | Fibrinolytic Agents - therapeutic use | Thrombosis - blood | Thrombosis - prevention & control | Patient Education as Topic | Polysaccharides - therapeutic use | Drug Administration Schedule | Administration, Oral | Hemorrhage - therapy | Polysaccharides - adverse effects | Evidence-Based Medicine | Randomized Controlled Trials as Topic | International Normalized Ratio | Thrombosis - drug therapy | Hemorrhage - chemically induced | Infusions, Intravenous | Self Care | Polysaccharides - pharmacokinetics | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2012, Volume 110, Issue 3, pp. 453 - 460
Journal Article
Stroke, ISSN 0039-2499, 04/2019, Volume 50, Issue 4, pp. 873 - 879
... data for patients using direct oral anticoagulants (DOACs) are limited. METHODS—Data from our registry including all patients admitted with acute cerebral ischemia... 
direct oral anticoagulants | atrial fibrillation | WARFARIN | anticoagulants | plasma level | THROMBOLYSIS | PERIPHERAL VASCULAR DISEASE | ischemic stroke | CLINICAL NEUROLOGY | ATRIAL-FIBRILLATION | Stroke (Disease) | Cerebral ischemia | Usage | Anticoagulants (Medicine) | Patient outcomes | Risk factors
Journal Article